Cibus (NASDAQ:CBUS - Get Free Report) is set to announce its earnings results after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of ($0.89) per share for the quarter. Investors that wish to listen to the company's conference call can do so using this link.
Cibus (NASDAQ:CBUS - Get Free Report) last announced its earnings results on Thursday, August 8th. The company reported ($1.14) EPS for the quarter, missing the consensus estimate of ($0.81) by ($0.33). Cibus had a negative return on equity of 29.05% and a negative net margin of 9,856.84%. The company had revenue of $0.84 million for the quarter, compared to analyst estimates of $0.44 million. During the same quarter last year, the business posted ($3.05) earnings per share. On average, analysts expect Cibus to post $-4 EPS for the current fiscal year and $-3 EPS for the next fiscal year.
Cibus Price Performance
NASDAQ:CBUS traded down $0.08 during trading hours on Thursday, reaching $3.99. 87,968 shares of the stock were exchanged, compared to its average volume of 134,979. The stock has a market cap of $85.96 million, a PE ratio of -0.22 and a beta of 1.81. Cibus has a twelve month low of $2.86 and a twelve month high of $23.18. The firm has a 50 day moving average of $4.46 and a 200 day moving average of $9.35.
Analysts Set New Price Targets
Several analysts recently issued reports on CBUS shares. Canaccord Genuity Group upgraded Cibus to a "strong-buy" rating in a report on Friday, July 19th. Alliance Global Partners dropped their price target on shares of Cibus from $25.00 to $23.50 and set a "buy" rating on the stock in a research report on Tuesday, September 24th. Finally, Canaccord Genuity Group reissued a "buy" rating and issued a $20.00 price objective on shares of Cibus in a research report on Tuesday, October 22nd.
View Our Latest Stock Report on CBUS
Cibus Company Profile
(
Get Free Report)
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Read More
Before you consider Cibus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cibus wasn't on the list.
While Cibus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
